Table.2 Comorbidities among COVID-19 patients with different severity
From: Early predictors and screening tool developing for severe patients with COVID-19
Comorbidity | Fatal cases (n = 37) | Severe cases (n = 123) | Common cases (n = 653) | χ2 | P |
|---|---|---|---|---|---|
Hypertension | 59.5% | 17.4% | 12.6% | 58.7 | < 0.001 |
Diabetes | 21.6% | 7.0% | 3.9% | 22.8 | < 0.001 |
Cardiovascular diseases | 21.6% | 5.2% | 4.1% | 22.2 | < 0.001 |
Chronic kidney diseasea | 16.2% | 7.0% | 0.3% | 58.6 | < 0.001 |
Chronic lung diseasea | 2.7% | 2.6% | 2.0% | 0.3 | 0.874 |
Chronic liver diseasea | 0 | 1.7% | 0.7% | 1.8 | 0.412 |
Other diseases | 13.5% | 16.5% | 7.0% | 12.0 | 0.002 |